Literature DB >> 22708598

Cortical circuit dysfunction and cognitive deficits in schizophrenia--implications for preemptive interventions.

David A Lewis1.   

Abstract

Schizophrenia is a devastating disorder that is common, usually chronic, frequently associated with substantial co-morbidity for addictive and medical disorders and, as a consequence, very costly in both personal and economic terms. At present, no proven means for preventing or modifying the course of the illness exist. This review discusses evidence supporting the ideas that: (i) impairments in certain cognitive processes are the core feature of schizophrenia; (ii) these cognitive impairments reflect abnormalities in specific cortical circuits; and (iii) these circuitry abnormalities arise during childhood-adolescence. The implications of these findings for the development and implementation of safe, preemptive, disease-modifying interventions in individuals at high risk for a clinical diagnosis of schizophrenia are considered.
© 2012 The Author. European Journal of Neuroscience © 2012 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22708598      PMCID: PMC3383640          DOI: 10.1111/j.1460-9568.2012.08156.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  108 in total

1.  Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia.

Authors:  Nutan Kolluri; Zhuoxin Sun; Allan R Sampson; David A Lewis
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

2.  Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia.

Authors:  J J Hill; T Hashimoto; D A Lewis
Journal:  Mol Psychiatry       Date:  2006-06       Impact factor: 15.992

Review 3.  The reduced neuropil hypothesis: a circuit based model of schizophrenia.

Authors:  L D Selemon; P S Goldman-Rakic
Journal:  Biol Psychiatry       Date:  1999-01-01       Impact factor: 13.382

Review 4.  Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies.

Authors:  R Grant Steen; Courtney Mull; Robert McClure; Robert M Hamer; Jeffrey A Lieberman
Journal:  Br J Psychiatry       Date:  2006-06       Impact factor: 9.319

5.  Functional neuroimaging of working memory in schizophrenia: task performance as a moderating variable.

Authors:  Jared X Van Snellenberg; Ivan J Torres; Allen E Thornton
Journal:  Neuropsychology       Date:  2006-09       Impact factor: 3.295

Review 6.  Cortical inhibitory neurons and schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; David W Volk
Journal:  Nat Rev Neurosci       Date:  2005-04       Impact factor: 34.870

Review 7.  Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes.

Authors:  L Dixon
Journal:  Schizophr Res       Date:  1999-03-01       Impact factor: 4.939

8.  Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents.

Authors:  M Davidson; A Reichenberg; J Rabinowitz; M Weiser; Z Kaplan; M Mark
Journal:  Am J Psychiatry       Date:  1999-09       Impact factor: 18.112

9.  Heritability estimates for psychotic disorders: the Maudsley twin psychosis series.

Authors:  A G Cardno; E J Marshall; B Coid; A M Macdonald; T R Ribchester; N J Davies; P Venturi; L A Jones; S W Lewis; P C Sham; I I Gottesman; A E Farmer; P McGuffin; A M Reveley; R M Murray
Journal:  Arch Gen Psychiatry       Date:  1999-02

10.  The lifetime risk of suicide in schizophrenia: a reexamination.

Authors:  Brian A Palmer; V Shane Pankratz; John Michael Bostwick
Journal:  Arch Gen Psychiatry       Date:  2005-03
View more
  52 in total

1.  Delays in GABAergic interneuron development and behavioral inhibition after prenatal stress.

Authors:  Stephanie J Lussier; Hanna E Stevens
Journal:  Dev Neurobiol       Date:  2016-01-22       Impact factor: 3.964

Review 2.  Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance.

Authors:  Melissa L Perreault; Ahmed Hasbi; Brian F O'Dowd; Susan R George
Journal:  Neuropsychopharmacology       Date:  2013-06-18       Impact factor: 7.853

Review 3.  Decision making: from neuroscience to psychiatry.

Authors:  Daeyeol Lee
Journal:  Neuron       Date:  2013-04-24       Impact factor: 17.173

4.  Dorsal raphe neuroinflammation promotes dramatic behavioral stress dysregulation.

Authors:  Alexis R Howerton; Alison V Roland; Tracy L Bale
Journal:  J Neurosci       Date:  2014-05-21       Impact factor: 6.167

5.  Cholecystokinin-Expressing Interneurons of the Medial Prefrontal Cortex Mediate Working Memory Retrieval.

Authors:  Robin Nguyen; Sridevi Venkatesan; Mary Binko; Jee Yoon Bang; Janine D Cajanding; Chloe Briggs; Derya Sargin; Itaru Imayoshi; Evelyn K Lambe; Jun Chul Kim
Journal:  J Neurosci       Date:  2020-01-31       Impact factor: 6.167

6.  Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction.

Authors:  Adam G Walker; Cody J Wenthur; Zixiu Xiang; Jerri M Rook; Kyle A Emmitte; Colleen M Niswender; Craig W Lindsley; P Jeffrey Conn
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

Review 7.  Altering the course of schizophrenia: progress and perspectives.

Authors:  Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger
Journal:  Nat Rev Drug Discov       Date:  2016-03-04       Impact factor: 84.694

Review 8.  Gephyrin: a master regulator of neuronal function?

Authors:  Shiva K Tyagarajan; Jean-Marc Fritschy
Journal:  Nat Rev Neurosci       Date:  2014-03       Impact factor: 34.870

Review 9.  Layer 3 Excitatory and Inhibitory Circuitry in the Prefrontal Cortex: Developmental Trajectories and Alterations in Schizophrenia.

Authors:  Gil D Hoftman; Dibyadeep Datta; David A Lewis
Journal:  Biol Psychiatry       Date:  2016-06-04       Impact factor: 13.382

10.  Afferent drive of medial prefrontal cortex by hippocampus and amygdala is altered in MAM-treated rats: evidence for interneuron dysfunction.

Authors:  Behnaz Esmaeili; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2013-03-07       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.